8
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      Call for Papers: Supportive Care - Essential for Modern Oncology

      Submit here before December 31, 2024

      About Oncology Research and Treatment: 2.0 Impact Factor I 3.2 CiteScore I 0.521 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Invasive Cystic Hypersecretory Ductal Carcinoma of Breast: Challenges in Diagnosis and Management

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cystic hypersecretory lesions of the breast are a spectrum of conditions ranging from cystic hypersecretory hyperplasia with atypia and invasive cystic hypersecretory carcinoma (CHC). It is a subtype of ductal carcinoma of the breast. The tumour is very infrequent and hence, extensive literature is limited. This culminates in the fact that it does not feature as part of the WHO classification of breast tumours. However, a good knowledge about its distinct pathological features can avert misdiagnosis and help differentiate CHC from other conditions. Thus far, only 22 cases of invasive CHC have been reported, of which 3 were microinvasive. Only 7 cases of axillary lymph node metastasis have been documented. We report a case of invasive CHC of the breast that was metastatic to the axilla and refractory to neoadjuvant chemotherapy. Our case report aims to add to the literature on the disease, aiming to support large-scale studies in the future in order to elaborate on its clinical and biological characteristics.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: not found
          • Article: not found

          Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potential

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cystic hypersecretory duct carcinoma of the breast.

              This report describes a grossly and microscopically distinctive multicystic form of duct carcinoma of the breast which we have termed cystic hypersecretory duct carcinoma. The outstanding morphologic feature is marked secretory activity with the formation of dilated ducts and cysts containing homogeneous, eosinophilic material which resembles thyroid colloid. The inconspicuous epithelium lining the cysts gives rise to micropapillary carcinoma which also occurs in associated ducts. A biopsy that consists entirely of cystic elements, lacking the papillary component, should be termed cystic hypersecretory hyperplasia rather than carcinoma. This may be a persistent condition with the potential to evolve into carcinoma. Eight patients with cystic hypersecretory duct carcinoma were studied, ranging in age from 32 to 78 years (mean 54). In two cases there was coexistent invasive carcinoma, presenting as inflammatory carcinoma with bone metastases in one woman and with a single axillary lymph node metastasis in another. Six patients with intraductal carcinoma treated with mastectomy or local excision have remained well, the longest follow-up being 2 years. Histochemical studies were negative for thyroglobulin in all cases studied. Some lesions were positive for one or more of the following: mucin by mucicarmine stain; carcinoembryonic antigen; alpha-lactalbumin; mouse mammary tumor virus GP52 antigen. Cystic hypersecretory duct carcinoma is morphologically distinguishable from juvenile (secretory) carcinoma and from mucinous (colloid) carcinoma. Longer follow-up and study of additional cases will be necessary to determine if this lesion has distinctive clinical characteristics.
                Bookmark

                Author and article information

                Journal
                Case Rep Oncol
                Case Rep Oncol
                CRO
                CRO
                Case Reports in Oncology
                S. Karger AG (Basel, Switzerland )
                1662-6575
                1 November 2023
                Jan-Dec 2023
                1 November 2023
                : 16
                : 1
                : 1259-1266
                Affiliations
                [a ]Department of General Surgery, King Hamad University Hospital, Busaiteen, Kingdom of Bahrain
                [b ]Department of Pathology, King Hamad University Hospital, Busaiteen, Kingdom of Bahrain
                Author notes
                Correspondence to: Noof Alshaibani, noof.alshaibani@ 123456khuh.org.bh
                Article
                533441
                10.1159/000533441
                10619999
                37920380
                66d72b69-1da9-43d5-b445-db01a6ebaa66
                © 2023 The Author(s). Published by S. Karger AG, Basel

                This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) ( http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.

                History
                : 11 May 2023
                : 3 August 2023
                : 2023
                Page count
                Figures: 6, References: 18, Pages: 8
                Funding
                No funding was received for this work.
                Categories
                Case Report

                Oncology & Radiotherapy
                invasive cystic hypersecretory carcinoma,cystic hypersecretory hyperplasia,invasive ductal carcinoma of breast,cystic breast tumour

                Comments

                Comment on this article